Leading the way: advances in the diagnosis, treatment, and management of neuropsychiatric illnesses.
Gorman
Jack M
JM
D000279:Administration, Cutaneous; D000287:Administration, Topical; D001921:Brain / Q000503:physiopathology*; D003865:Major Depressive Disorder / Q000188:drug therapy; D006801:Humans; D001523:Mental Disorders / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D010624:Phenelzine / Q000627:therapeutic use; D011570:Psychiatry / Q000639:trends*; D012642:Selegiline / Q000627:therapeutic use; D013001:Somatoform Disorders / Q000523:psychology; D014191:Tranylcypromine / Q000627:therapeutic use
D008996:Monoamine Oxidase Inhibitors; D012642:Selegiline; D014191:Tranylcypromine; D010624:Phenelzine